Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00620932
Other study ID # Pro00002501
Secondary ID
Status Withdrawn
Phase N/A
First received February 12, 2008
Last updated October 25, 2013
Start date January 2008
Est. completion date November 2008

Study information

Verified date October 2013
Source Duke University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The primary objective is to determine the feasibility and acceptability of a home-based endurance exercise program among men diagnosed with clinically localized prostate cancer.


Description:

Approximately 40 people will take part in this study and all of these people will take part at Duke University Medical Center.

Participation in this study involves the following.

- We will ask you to perform a cardiopulmonary exercise test (walking stress test) to determine if you have any undiagnosed cardiovascular health problems that may limit your ability to participate in an exercise training program. This test will take place at the Duke Center for Living on Duke University Campus.

- Complete a body composition assessment. This test is designed to determine your body fat and lean body tissue (muscle mass) percentage and will consist of you sitting quietly in a chamber with appropriate medical supervision. This test also will take place at the Duke Center for Living on Duke University Campus.

- Complete two questionnaires one at the beginning and one at the end that asks about how you are feeling and about your physical activity levels. The questionnaire takes about 20-30 minutes.

- Provide two blood samples one at the beginning and one at the end to measure levels of cardiovascular disease risk factors (cholesterol levels, c-reactive protein and insulin levels) in your blood that may be influenced by exercise. Blood collection will be drawn by medical staff at Duke University. The amount of blood drawn is approximately 2 teaspoons (10ml).

- We will also collect information on how much treatment you receive as well as how many and what type of side-effects you have from your medical treatment. This information will be obtained from your medical chart following the completion of your treatment.

Following the successful completion of all initial tests and procedures (as described above), you will be randomly assigned (like flipping a coin) to one of the following two groups:

1. Exercise Training Group: You will be given a customized training program aimed at increasing cardiorespiratory fitness. You will be asked to exercise 3 to 5 times per week. All sessions will include a 5 minute warm-up and 5 minute cool-down at the beginning and end of each session totaling 30-45 minutes per session. You will also receive a heart rate monitor to record each exercise session to monitor adherence and compliance. You will receive telephone calls every two weeks to provide encouragement, outline goals, and provide feedback on study progress.

OR

2. Wait-List Control Group: You will be asked to maintain your usual exercise levels during the 6 month study period. You will receive telephone calls to report your levels of exercise during the study. After study completion you will receive a heart rate monitor and an individualized exercise prescription based on your cardiorespiratory fitness test at the end of the study period (6 months).


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date November 2008
Est. primary completion date November 2008
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Legal age (>18 years old)

2. An interval of at least 6 weeks between prior radical prostatectomy and study enrollment

3. Karnofsky performance status of at least 70% at study entry

4. Estimated life expectancy of =6 months

5. Ability to read and understand English

6. Attending urologist approval

7. Signed informed consent

8. Willingness to be randomized; and

9. No contraindications to exercise as recommended by the American Thoracic Society

Exclusion Criteria:

1. Acute myocardial infarction (6 weeks)

2. Unstable angina

3. Uncontrolled arrhythmias causing symptoms or hemodynamic compromise

4. Syncope

5. Acute endocarditis

6. Acute myocarditis or pericarditis

7. Uncontrolled heart failure

8. Acute pulmonary embolus or pulmonary infarction

9. Thrombosis of lower extremities

10. Suspected dissecting aneurysm

11. Uncontrolled asthma

12. Pulmonary edema

13. Room air desaturation at rest =85%

14. Respiratory failure

15. Acute noncardiopulmonary disorder that may affect exercise performance or be aggravated by exercise; and

16. Mental impairment leading to inability to cooperate

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise
Patients will be randomly assigned to groups and will either be given an exercise program individually tailored to them for them to participate in for 6 months or else be wait-listed for 6 months and remain on whatever exercise regimen they were already on.

Locations

Country Name City State
United States Duke University Medical Center Preston Robert Tisch Brain Tumor Center Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiorespiratory Fitness will be determined using a incremental treadmill test with 12-lead ECG monitoring. 6 months No
Secondary Fasting lipids will be assessed. 6 months No
See also
  Status Clinical Trial Phase
Completed NCT02924974 - Spinal Morphine in Robotic Assisted Radical Prostatectomy Phase 4
Completed NCT02369211 - Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV) Phase 4
Recruiting NCT04933084 - Pre-operative Education Modalities to Decrease Opioid Use N/A
Completed NCT06020287 - The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach
Active, not recruiting NCT04172519 - Pelvic Floor Muscles Training After Radical Prostatectomy. N/A
Not yet recruiting NCT05576766 - Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy N/A
Terminated NCT01008709 - Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery N/A
Completed NCT03714984 - The Efficacy of Pre-operative Educational Pelvic Floor Intervention on Urinary Continence N/A
Recruiting NCT06274125 - Evaluation of Kidney Damage Using NGAL Measurements
Completed NCT03884335 - Radical Laparoscopic Prostatectomy. Enhanced Recovery After Surgery (ERAS) Program N/A
Completed NCT03721029 - Intraoperative Nerve Monitoring During Robotic-assisted Radical Prostatectomy N/A
Withdrawn NCT02621684 - Physical Activity Intervention in African American Men After Radical Prostatectomy N/A
Completed NCT06119568 - Safety and Performance Assessment of a First Four Arms on Demand Open Robotic Solution for Assisted PN, RN and RP N/A
Recruiting NCT04261777 - Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients Phase 3
Recruiting NCT03080116 - Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy Phase 2
Recruiting NCT05008900 - Timing of Post-prostatectomy PSMA Imaging Phase 2
Completed NCT01582477 - TAP-patients With Robotic Assisted Lap Prostatectomy Phase 4
Completed NCT05242198 - Rectus Sheath Block May Relieve Urethral Catheter Pain N/A
Not yet recruiting NCT03061760 - Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy N/A
Recruiting NCT04404738 - MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology N/A